1. Home
  2. FAF vs MIRM Comparison

FAF vs MIRM Comparison

Compare FAF & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First American Corporation (New)

FAF

First American Corporation (New)

HOLD

Current Price

$63.42

Market Cap

6.3B

Sector

Finance

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$95.14

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FAF
MIRM
Founded
1889
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
5.7B
IPO Year
2009
2019

Fundamental Metrics

Financial Performance
Metric
FAF
MIRM
Price
$63.42
$95.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
12
Target Price
$79.00
$115.33
AVG Volume (30 Days)
1.0M
788.7K
Earning Date
04-22-2026
05-06-2026
Dividend Yield
3.45%
N/A
EPS Growth
376.19
74.59
EPS
6.00
N/A
Revenue
$7,452,200,000.00
$19,138,000.00
Revenue This Year
$8.08
$26.22
Revenue Next Year
$5.46
$22.04
P/E Ratio
$10.61
N/A
Revenue Growth
21.61
N/A
52 Week Low
$53.95
$38.22
52 Week High
$71.47
$109.28

Technical Indicators

Market Signals
Indicator
FAF
MIRM
Relative Strength Index (RSI) 53.50 52.92
Support Level $61.26 $85.35
Resistance Level $63.79 $98.03
Average True Range (ATR) 1.40 3.62
MACD 0.61 0.46
Stochastic Oscillator 88.59 69.11

Price Performance

Historical Comparison
FAF
MIRM

About FAF First American Corporation (New)

First American Financial Corp is a financial services business providing insurance through segments: Title insurance and related services segment include real estate insurance, property closing services, third-party handling of real estate funds (escrow), risk mitigation, real estate data products, and related real estate transaction services; The home warranty segment provides residential service contracts that cover residential systems, such as heating and air conditioning systems, and certain appliances against failures that occur as the result of normal usage during the coverage period; and The corporate segment includes investments in venture-stage companies, certain financing facilities and corporate services supporting the company's business operations.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: